Full-Time

Vice President

Biology

Updated on 5/10/2024

Alector

Alector

201-500 employees

Develops immuno-neurology therapies for neurodegenerative diseases

Biotechnology

Senior, Expert

San Bruno, CA, USA

Requirements
  • Ph.D. in Immunology or Neuroscience with over 20 years in academia or in the biotech/pharmaceutical industry, including 10+ years in drug discovery.
  • Expertise and scientific achievement in Immunology/Neuroscience related neurodegenerative disorders.
  • Deep experience leading drug discovery programs to the IND stage
  • Highly proficient with all facets of drug discovery and ability to collaborate with peers in other departments to ensure project advancement.
  • Excellent people leader and mentor
  • Ability to design and execute translatable proof of concept studies.
  • Expertise in in vivo studies in rodents.
  • Proactive, innovative, with good problem-solving skills
  • Ability to work in a cross-functional team and matrix environment.
  • Ability to influence peers, colleagues, and senior leadership
Responsibilities
  • Set strategy for research areas and maintain strategic focus across multiple complex drug discovery programs, prioritize resource allocation, and drive decisions consistent with company goals.
  • Work closely with the CSO to incorporate new ideas and translate them with the team into programs.
  • Provide scientific, strategic, and mentorship to an enthusiastic team of scientists.
  • Maintain an excellent grasp on emerging areas of immunology and neuroscience research that are potential competitive advantages, including engaging in external collaborations in support of discovery and development programs.
  • Collaborate with business partners to devise comprehensive strategies that use innovative technologies.
  • Seamlessly integrate discovered targets into preclinical plans enabling well-informed decision-making throughout the preclinical phase.

Alector Therapeutics uses immuno-neurology and immuno-oncology technologies to develop medicines that address neurodegenerative diseases. This focus not only positions them at the forefront of addressing complex health issues but also enhances their ability to innovate within the pharmaceutical industry. Working at this company offers a unique opportunity to contribute to cutting-edge clinical trials and be part of a team that empowers the body's immune system to combat neurological disorders, making it an excellent place for professionals passionate about pioneering health solutions and research in biotechnology.

Company Stage

IPO

Total Funding

$269.5M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

1%

1 year growth

0%

2 year growth

8%